(Q34514039)

2 August 2017

1 reference

title

Statin therapy after acute myocardial infarction: are we adequately treating high-risk patients? (English)

1 reference

2 August 2017

1 reference

myocardial infarction

1 reference

acute myocardial infarction

inferred from title

1 reference

1

Gregg C Fonarow

1 reference

2 August 2017

publication date

1 March 2002

1 reference

Current Atherosclerosis Reports

2 August 2017

published in

1 reference

2 August 2017

volume

4

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

99-106

1 reference

Guide to Preventive Cardiology for Women.AHA/ACC Scientific Statement Consensus panel statement

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11883-002-0032-4

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-002-0032-4

A case-management system for coronary risk factor modification after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-002-0032-4

When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-002-0032-4

Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: data from the National Registry of Myocardial Infarction 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-002-0032-4

Smoking cessation after acute myocardial infarction: effects of a nurse-managed intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-002-0032-4

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

21 January 2018

1 reference

12 December 2020

In-hospital initiation of lipid-lowering therapy for patients with coronary heart disease: the time is now

1 reference

12 December 2020

The value of lowering cholesterol after myocardial infarction

1 reference

12 December 2020

Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) Invest

1 reference

12 December 2020

Strategies for implementing lipid-lowering therapy: pharmacy-based approach

1 reference

12 December 2020

Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme

1 reference

12 December 2020

The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals

1 reference

12 December 2020

Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group

1 reference

12 December 2020

Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

1 reference

12 December 2020

Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)

1 reference

12 December 2020

Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease

1 reference

12 December 2020

Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease

1 reference

12 December 2020

Treatment of Hypercholesterolemia by a Clinical Nurse Using a Stepped-Care Protocol in a Nonvolunteer Population

1 reference

12 December 2020

Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program

1 reference

12 December 2020

The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia

1 reference

12 December 2020

Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure

1 reference

12 December 2020

Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality

1 reference

12 December 2020

Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

1 reference

12 December 2020

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials

1 reference

12 December 2020

Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction

1 reference

12 December 2020

Impact of evidence-based "clinical judgment" on the number of American adults requiring lipid-lowering therapy based on updated NHANES III data. National Health and Nutrition Examination Survey.

1 reference

12 December 2020

Clinical goals and performance measures for cholesterol management in secondary prevention of coronary heart disease

1 reference

12 December 2020

Rationale and design of the Cardiac Hospitalization Atherosclerosis Management Program at the University of California Los Angeles.

1 reference

12 December 2020

Lipid lowering in a multidisciplinary clinic compared with primary physician management

1 reference

12 December 2020

AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update

1 reference

12 December 2020

Dietary reduction of serum cholesterol concentration: time to think again

1 reference

12 December 2020

27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 8. Organization of preventive cardiology service

1 reference

12 December 2020

27th Bethesda Conference. Matching the Intensity of Risk Factor Management with the Hazard for Coronary Disease Events. September 14-15, 1995

1 reference

12 December 2020

Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994.

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Early statin treatment following acute myocardial infarction and 1-year survival

1 reference

12 December 2020

Myocardial injury: the acute phase response and lipoprotein metabolism

1 reference

12 December 2020

Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project

1 reference

12 December 2020

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

12 December 2020

10.1007/S11883-002-0032-4

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1047279202

0 references

1 reference